Condition: 22q11.2 Deletion Syndrome · Sponsor: Hôpital le Vinatier
The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome
This description comes directly from the study's public registry record.
Caroline DEMILY, MD PH · 0450915163 · caroline.demily@ch-le-vinatier.fr
Véronique VIAL · 0437915531 · veronique.vial@ch-le-vinatier.fr
Always discuss trial participation with your own doctor first.
| Hopital Vinatier | Lyon, Auvergne-Rhône-Alpes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04639388